Log In
Print
BCIQ
Print
Print this Print this
 

ALT-801, TCR-IL-2

  Manage Alerts
Collapse Summary General Information
Company Altor BioScience Corp.
DescriptionSoluble tumor antigen-specific T cell receptor (TCR) linked to interleukin-2 (IL-2)
Molecular Target p53
Mechanism of ActionCell therapy
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today